Dissociation of hyperglycemia from altered vascular contraction and relaxation mechanisms in caveolin-1 null mice

Journal of Pharmacology and Experimental Therapeutics

Volumn 348, Issue 2, 2014, Pages 260-270

  Pojoga, Luminita H ^a   Yao, Tham M ^a   Opsasnick, Lauren A ^b   Garza, Amanda E ^a   Reslan, Ossama M ^b   Adler, Gail K ^a   Williams, Gordon H ^a   Khalil, Raouf A ^b  

^a Cardiovascular Endocrine Section   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1H 1,2,4 OXADIAZOLO[4,3 A]QUINOXALIN 1 ONE; ACETYLCHOLINE; CAVEOLIN 1; ENDOTHELIAL NITRIC OXIDE SYNTHASE; GLUCOSE; METFORMIN; N(G) NITROARGININE METHYL ESTER; NITROPRUSSIDE SODIUM; PHENYLEPHRINE; PLACEBO; POTASSIUM CHLORIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; AORTA CONSTRICTION; AORTA RELAXATION; ARTICLE; BLOOD PRESSURE; CARDIOVASCULAR FUNCTION; CAV 1 GENE; CONTROLLED STUDY; DRUG POTENCY; ENDOTHELIUM; GENE; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HEART VASCULAR DYSFUNCTION; HYPERGLYCEMIA; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL;

EID: 84893038971     PISSN: 00223565     EISSN: 15210103     Source Type: Journal    
DOI: 10.1124/jpet.113.209189     Document Type: Article

References (55)

1. Agard C, Rolli-Derkinderen M, Dumas-de-La-Roque E, Rio M, Sagan C, Savineau JP, Loirand G, and Pacaud P (2009) Protective role of the antidiabetic drug metformin against chronic experimental pulmonary hypertension. Br J Pharmacol 158: 1285-1294.
2. Agarwal N, Rice SP, Bolusani H, Luzio SD, Dunseath G, Ludgate M, and Rees DA (2010) Metformin reduces arterial stiffness and improves endothelial function in young women with polycystic ovary syndrome: a randomized, placebo-controlled, crossover trial. J Clin Endocrinol Metab 95:722-730.
3. Anter E, Thomas SR, Schulz E, Shapira OM, Vita JA, and Keaney JF, Jr (2004) Activation of endothelial nitric-oxide synthase by the p38 MAPK in response to black tea polyphenols. J Biol Chem 279:46637-46643.
4. Asterholm IW, Mundy DI, Weng J, Anderson RG, and Scherer PE (2012) Altered mitochondrial function and metabolic inflexibility associated with loss of caveolin-1. Cell Metab 15:171-185.
5. Bailey CJ, Gross JL, Hennicken D, Iqbal N, Mansfield TA, and List JF (2013) Dapagliflozin add-on to metformin in type 2 diabetes inadequately controlled with metformin: a randomized, double-blind, placebo-controlled 102-week trial. BMC Med 11:43.
6. Batova S, DeWever J, Godfraind T, Balligand JL, Dessy C, and Feron O (2006) The calcium channel blocker amlodipine promotes the unclamping of eNOS from caveolin in endothelial cells. Cardiovasc Res 71:478-485.
7. Bender SB, McGraw AP, Jaffe IZ, and Sowers JR (2013) Mineralocorticoid receptormediated vascular insulin resistance: an early contributor to diabetes-related vascular disease? Diabetes 62:313-319.
8. Bhalla RC, Toth KF, Tan E, Bhatty RA, Mathias E, and Sharma RV (1996) Vascular effects of metformin: possible mechanisms for its antihypertensive action in the spontaneously hypertensive rat. Am J Hypertens 9:570-576.
9. Brands MW and Hopkins TE (1996) Poor glycemic control induces hypertension in diabetes mellitus. Hypertension 27:735-739.
10. Catalán V, Gómez-Ambrosi J, Rodríguez A, Silva C, Rotellar F, Gil MJ, Cienfuegos JA, Salvador J, and Frühbeck G (2008) Expression of caveolin-1 in human adipose tissue is upregulated in obesity and obesity-associated type 2 diabetes mellitus and related to inflammation. Clin Endocrinol (Oxf ) 68:213-219.
11. Chen XL, Panek K, and Rembold CM (1997) Metformin relaxes rat tail artery by repolarization and resultant decreases in Ca21 influx and intracellular [Ca21]. J Hypertens 15:269-274.
12. Chen ZP, Mitchelhill KI, Michell BJ, Stapleton D, Rodriguez-Crespo I, Witters LA, Power DA, Ortiz de Montellano PR, and Kemp BE (1999) AMP-activated protein kinase phosphorylation of endothelial NO synthase. FEBS Lett 443:285-289.
13. Cohen AW, Razani B, Wang XB, Combs TP, Williams TM, Scherer PE, and Lisanti MP (2003) Caveolin-1-deficient mice show insulin resistance and defective insulin receptor protein expression in adipose tissue. Am J Physiol Cell Physiol 285: C222-C235.
14. Cornwell TL and Lincoln TM (1989) Regulation of intracellular Ca21 levels in cultured vascular smooth muscle cells: reduction of Ca21 by atriopeptin and 8-bromocyclic GMP is mediated by cyclic GMP-dependent protein kinase. J Biol Chem 264: 1146-1155.
15. Dimopoulos GJ, Semba S, Kitazawa K, Eto M, and Kitazawa T (2007) Ca21-dependent rapid Ca21 sensitization of contraction in arterial smooth muscle. Circ Res 100:121-129.
16. Drab M, Verkade P, Elger M, Kasper M, Lohn M, Lauterbach B, Menne J, Lindschau C, Mende F, and Luft FC, et al. (2001) Loss of caveolae, vascular dysfunction, and pulmonary defects in caveolin-1 gene-disrupted mice. Science 293:2449-2452.
17. Evgenov OV, Pacher P, Schmidt PM, Haskó G, Schmidt HH, and Stasch JP (2006) NO-independent stimulators and activators of soluble guanylate cyclase: discovery and therapeutic potential. Nat Rev Drug Discov 5:755-768.
18. Fernández-Rojo MA, Gongora M, Fitzsimmons RL, Martel N, Martin SD, Nixon SJ, Brooks AJ, Ikonomopoulou MP, Martin S, and Lo HP,, et al. (2013) Caveolin-1 is necessary for hepatic oxidative lipid metabolism: evidence for crosstalk between caveolin-1 and bile acid signaling. Cell Rep 4:238-247.
19. Feron O, Saldana F, Michel JB, and Michel T (1998) The endothelial nitric-oxide synthase-caveolin regulatory cycle. J Biol Chem 273:3125-3128.
20. Gallo A, Ceolotto G, Pinton P, Iori E, Murphy E, Rutter GA, Rizzuto R, Semplicini A, and Avogaro A (2005) Metformin prevents glucose-induced protein kinase C-beta2 activation in human umbilical vein endothelial cells through an antioxidant mechanism. Diabetes 54:1123-1131.
21. Hall JE, Brands MW, and Shek EW (1996) Central role of the kidney and abnormal fluid volume control in hypertension. J Hum Hypertens 10:633-639.
22. Hauton D (2011) Does long-term metformin treatment increase cardiac lipoprotein lipase? Metabolism 60:32-42.
23. Heikkinen S, Argmann CA, Champy MF, and Auwerx J (2007) Evaluation of glucose homeostasis. Curr Protoc Mol Biol 29B3:1-22.
24. Heishi M, Ichihara J, Teramoto R, Itakura Y, Hayashi K, Ishikawa H, Gomi H, Sakai J, Kanaoka M, and Taiji M, et al. (2006) Global gene expression analysis in liver of obese diabetic db/db mice treated with metformin. Diabetologia 49:1647-1655.
25. Ishizaka N, Griendling KK, Lassègue B, and Alexander RW (1998) Angiotensin II type 1 receptor: relationship with caveolae and caveolin after initial agonist stimulation. Hypertension 32:459-466.
26. Kizub IV, Pavlova OO, Johnson CD, Soloviev AI, and Zholos AV (2010) Rho kinase and protein kinase C involvement in vascular smooth muscle myofilament calcium sensitization in arteries from diabetic rats. Br J Pharmacol 159:1724-1731.
27. Lastra G, Dhuper S, Johnson MS, and Sowers JR (2010) Salt, aldosterone, and insulin resistance: impact on the cardiovascular system. Nat Rev Cardiol 7: 577-584.
28. Lee CH, Poburko D, Sahota P, Sandhu J, Ruehlmann DO, and van Breemen C (2001) The mechanism of phenylephrine-mediated [Ca(21)](i) oscillations underlying tonic contraction in the rabbit inferior vena cava. J Physiol 534:641-650.
29. Li S, Liu C, Li N, Hao T, Han T, Hill DE, Vidal M, and Lin JD (2008) Genome-wide coactivation analysis of PGC-1alpha identifies BAF60a as a regulator of hepatic lipid metabolism. Cell Metab 8:105-117.
30. Lohmeier TE, Hildebrandt DA, Warren S, May PJ, and Cunningham JT (2005) Recent insights into the interactions between the baroreflex and the kidneys in hypertension. Am J Physiol Regul Integr Comp Physiol 288:R828-R836.
31. Mahrouf M, Ouslimani N, Peynet J, Djelidi R, Couturier M, Therond P, Legrand A, and Beaudeux JL (2006) Metformin reduces angiotensin-mediated intracellular production of reactive oxygen species in endothelial cells through the inhibition of protein kinase C. Biochem Pharmacol 72:176-183.
32. Matsumoto T, Noguchi E, Ishida K, Kobayashi T, Yamada N, and Kamata K (2008) Metformin normalizes endothelial function by suppressing vasoconstrictor prostanoids in mesenteric arteries from OLETF rats, a model of type 2 diabetes. Am J Physiol Heart Circ Physiol 295:H1165-H1176.
33. Minshall RD, Sessa WC, Stan RV, Anderson RG, and Malik AB (2003) Caveolin regulation of endothelial function. Am J Physiol Lung Cell Mol Physiol 285: L1179-L1183.
34. Morrow VA, Foufelle F, Connell JM, Petrie JR, Gould GW, and Salt IP (2003) Direct activation of AMP-activated protein kinase stimulates nitric-oxide synthesis in human aortic endothelial cells. J Biol Chem 278:31629-31639.
35. Muniyappa R, Lee S, Chen H, and Quon MJ (2008) Current approaches for assessing insulin sensitivity and resistance in vivo: advantages, limitations, and appropriate usage. Am J Physiol Endocrinol Metab 294:E15-E26.
36. Murphy JG and Khalil RA (2000) Gender-specific reduction in contractility and [Ca (21)](i) in vascular smooth muscle cells of female rat. Am J Physiol Cell Physiol 278:C834-C844.
37. Nobe K, Hashimoto T, and Honda K (2012) Two distinct dysfunctions in diabetic mouse mesenteric artery contraction are caused by changes in the Rho A-Rho kinase signaling pathway. Eur J Pharmacol 683:217-225.
38. Osuka K, Watanabe Y, Usuda N, Atsuzawa K, Yoshida J, and Takayasu M (2009) Modification of endothelial nitric oxide synthase through AMPK after experimental subarachnoid hemorrhage. J Neurotrauma 26:1157-1165.
39. Park KM, Trucillo M, Serban N, Cohen RA, and Bolotina VM (2008) Role of iPLA2 and store-operated channels in agonist-induced Ca21 influx and constriction in cerebral, mesenteric, and carotid arteries. Am J Physiol Heart Circ Physiol 294: H1183-H1187.
40. Pojoga LH, Adamová Z, Kumar A, Stennett AK, Romero JR, Adler GK, Williams GH, and Khalil RA (2010) Sensitivity of NOS-dependent vascular relaxation pathway to mineralocorticoid receptor blockade in caveolin-1-deficient mice. Am J Physiol Heart Circ Physiol 298:H1776-H1788.
41. Pojoga LH, Underwood PC, Goodarzi MO, Williams JS, Adler GK, Jeunemaitre X, Hopkins PN, Raby BA, Lasky-Su J, and Sun B, et al. (2011) Variants of the caveolin-1 gene: a translational investigation linking insulin resistance and hypertension. J Clin Endocrinol Metab 96:E1288-E1292.
42. Pojoga LH, Yao TM, Sinha S, Ross RL, Lin JC, Raffetto JD, Adler GK, Williams GH, and Khalil RA (2008) Effect of dietary sodium on vasoconstriction and eNOSmediated vascular relaxation in caveolin-1-deficient mice. Am J Physiol Heart Circ Physiol 294:H1258-H1265.
43. Razani B, Engelman JA, Wang XB, Schubert W, Zhang XL, Marks CB, Macaluso F, Russell RG, Li M, and Pestell RG, et al. (2001) Caveolin-1 null mice are viable but show evidence of hyperproliferative and vascular abnormalities. J Biol Chem 276: 38121-38138.
44. Salamanca DA and Khalil RA (2005) Protein kinase C isoforms as specific targets for modulation of vascular smooth muscle function in hypertension. Biochem Pharmacol 70:1537-1547.
45. Salani B, Maffioli S, Hamoudane M, Parodi A, Ravera S, Passalacqua M, Alama A, Nhiri M, Cordera R, and Maggi D (2012) Caveolin-1 is essential for metformin inhibitory effect on IGF1 action in non-small-cell lung cancer cells. FASEB J 26: 788-798.
46. Schulman IH and Zhou MS (2009) Vascular insulin resistance: a potential link between cardiovascular and metabolic diseases. Curr Hypertens Rep 11:48-55.
47. Shakirova Y, Bonnevier J, Albinsson S, Adner M, Rippe B, Broman J, Arner A, and Swärd K (2006) Increased Rho activation and PKC-mediated smooth muscle contractility in the absence of caveolin-1. AmJ Physiol Cell Physiol 291:C1326-C1335.
48. Sharma RV and Bhalla RC (1995) Metformin attenuates agonist-stimulated calcium transients in vascular smooth muscle cells. Clin Exp Hypertens 17:913-929.
49. Tanano I, Nagaoka T, Omae T, Ishibazawa A, Kamiya T, Ono S, and Yoshida A (2013) Dilation of porcine retinal arterioles to cilostazol: roles of eNOS phosphorylation via cAMP/protein kinase A and AMP-activated protein kinase and potassium channels. Invest Ophthalmol Vis Sci 54:1443-1449.
50. Uruno A, Sugawara A, Kanatsuka H, Kagechika H, Saito A, Sato K, Kudo M, Takeuchi K, and Ito S (2005) Upregulation of nitric oxide production in vascular endothelial cells by all-trans retinoic acid through the phosphoinositide 3-kinase/ Akt pathway. Circulation 112:727-736.
51. Ushio-Fukai M and Alexander RW (2006) Caveolin-dependent angiotensin II type 1 receptor signaling in vascular smooth muscle. Hypertension 48:797-803.
52. Venema RC, Venema VJ, Ju H, Harris MB, Snead C, Jilling T, Dimitropoulou C, Maragoudakis ME, and Catravas JD (2003) Novel complexes of guanylate cyclase with heat shock protein 90 and nitric oxide synthase. Am J Physiol Heart Circ Physiol 285:H669-H678.
53. Viollet B, Guigas B, Sanz Garcia N, Leclerc J, Foretz M, and Andreelli F (2012) Cellular and molecular mechanisms of metformin: an overview. Clin Sci (Lond) 122:253-270.
54. Williams GH (1994) Essential hypertension as an endocrine disease. Endocrinol Metab Clin North Am 23:429-444.
55. Yu J, Bergaya S, Murata T, Alp IF, Bauer MP, Lin MI, Drab M, Kurzchalia TV, Stan RV, and Sessa WC (2006) Direct evidence for the role of caveolin-1 and caveolae in mechanotransduction and remodeling of blood vessels. J Clin Invest 116:1284-1291.